Press releases
- GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community
- Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
- GSK announces positive pivotal phase III data for its respiratory syncytial virus (RSV) vaccine candidate for older adults
Tweets from GSK US
-
GSKUS @GSKUS
#News for #investors and #media: Today we have announced results from a clinical trial of a bivalent adjuvanted COVID-19 vaccine candidate we co-developed with @sanofi.
about 5 days ago -
GSKUS @GSKUS
Meet our #chemists today at the Empowering Women in Organic Chemistry conference @EWOC8. See you at the networking sessions! #EWOC8 #EWOC2022 #GSKChemistry #DiversityEquityInclusion #WomenInChemistry
about 6 days ago -
GSKUS @GSKUS
The work of #ERGs paves the way to change. Our LGBTQ+ ERG, Spectrum, has been at it for 26 years. Their voice helps guide areas of our business ranging from clinical trials to research to employee benefits. Learn about their impressive efforts #Pride20222gsk.to/39PB8cj9
about 6 days ago
